Chest CT vs X-ray after sarcoma surgery
Part of Brain & nervous system, Cancer clinical trials.
This trial compares CT scans to chest X-rays to monitor for lung cancer spread after surgery to remove soft tissue sarcoma. If you are at high risk of the sarcoma returning in your lungs, this study helps see which imaging method works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 1 and 85 years old.
- You had surgery to remove a soft tissue sarcoma from your arm, leg, or torso (trunk) with clear or close margins.
- Your sarcoma was aggressive (grade 2 or 3) and at least 5 cm in size.
- You had a chest CT within the last 30 days that showed no suspicious lung spots or only very small ones (4 mm or less).
- If you received chemotherapy or radiation therapy, it must be completed before you join.
- You do not have sarcoma in your chest wall/upper trunk that requires special imaging, or in your abdomen/retroperitoneum, and you do not have certain other sarcoma types.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two schedules of post-treatment check-ups to see which one better supports patient quality of life. You’d fill out surveys for up to two years to measure how you feel over time.
This trial compares a shorter course of radiation therapy with the standard longer course for people with soft tissue sarcoma in an arm or leg. The goal is to see if the shorter course works just as well and may be more convenient.
This trial tests a shorter, 3-week course of radiation therapy (using protons or standard X-rays) given before surgery for localized soft tissue sarcoma. It aims to see if this approach is safe and effective for treating the tumor while reducing side effects.
This trial tests a combination of immunotherapy (atezolizumab), chemotherapy (doxorubicin), and radiation before and after surgery for people with high-risk soft tissue sarcoma in the arm, leg, or trunk. The goal is to see if this approach can improve outcomes.
This trial tests whether adding a study drug called liposomal transcrocetin to radiation therapy before surgery improves outcomes for adults with soft tissue sarcoma in the arm or leg. The goal is to see if the combination is safe and effective.
This trial tests a new type of radiation called spatially fractionated radiation therapy (SFRT) given before surgery for large soft tissue sarcomas in the arm, leg, or trunk. The goal is to see if it helps shrink the tumor and improve treatment outcomes.
Hear when a new Alveolar Soft Part Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.